KPRX
KIORA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$1.75
−0.57%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-65.2%
Return on equity
-46.2%
Return on assets
-74.6%
Return on invested capital
0.00x
Asset turnover
-$8.5M
Cash from operations
$3.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026